4.7 Review

HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease

Journal

STEM CELL RESEARCH & THERAPY
Volume 4, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/scrt369

Keywords

-

Funding

  1. National Institutes of Health [UH2 EB017103, UH2 EB 17103]

Ask authors/readers for more resources

Our project team is developing an integrated microphysiological platform with functionally connected vascular, liver and cardiac microtissues derived from a single line of human pluripotent stem cells. The platform enables functional representation of human physiology in conjunction with real-time biological readouts (via imaging and homologous reporters for all three cell phenotypes) and compatibility with high-throughput/high-content analysis. In this paper, we summarize progress made over the first year of the grant.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available